ASSOCIATION OF NATIONAL ADVERTISERS, INC. for ASSOCIATION OF NATIONAL ADVERTISERS, INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Postal POS
Communicating with the USPS and PRC as it relates to pricing and postal reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
Taxation/Internal Revenue Code TAX
Issues relating to provisions in the IRS code that allow for the deduction of advertising expenses in the year in which they are incurred - both across the board prohibitions and pertaining to specific advertised products Specific discussions regarding the tax deduction for direct-to-consumer pharmaceutical advertising
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Beverage Industry BEV
Discussions relating to youth exposure to alcohol beverage advertising and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Tobacco TOB
Discussions generally on required warnings for cigarette packaging and advertisements, including e-cigarettes S. 3174/H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019, to ban ads for electronic delivery systems in a way that appeals to those under 21, as well as require disclosures on ads
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Food Industry (safety, labeling, etc.) FOO
Discussions generally on the marketing of food and beverage products to children
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Pharmacy PHA
Proposals relating to the regulation of direct-to-consumer prescription drug advertising Discussions over specific HHS/CMS proposal and proposed legislation to require televised direct-to-consumer prescription drug ads to contain list price information H.R. 4106, Responsibility in Drug Advertising Act of 2019, to prohibit direct-to-consumer prescription drug advertising for there years after FDA approval of a drug
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Computer Industry CPI
Discussions and meetings on draft legislation dealing with online privacy and data security, specifically through the industry's Privacy for America coalition Legislation dealing with a federal standard for online privacy and data protection S. 583, Digital Accountability and Transparency to Advance Privacy Act, requiring the FTC to develop data privacy procedures S. 748, to amend the Children's Online Privacy Protection Act of 1998 to strengthen protections relating to the online collection, use, and disclosure of personal information of children and minors, and for other purposes S. 783, Clean Slate for Kids Online Act, to amend the Children's Online Privacy Protection Act of 1998 to give Americans the option to delete personal information collected by internet operators of children under 13 H.R. 2013, Information Transparency & Personal Data Control Act, to require the FTC to issue regulations relating to privacy S. 1116, Balancing the Rights of Web Surfers Equally and Responsibly Act of 2019 (BROWSER Act); to require notice of privacy practices S. 1214, Privacy Bill of Rights Act, to require opt-in consent for collection of personal information and other practices relating to privacy S. 1578, Do Not Track Act, to require the FTC to implement a "do not track" system from data harvesting or online advertising H.R. 4978, Online Privacy Act of 2019, to set standards for collection and use of personal information S. 3330, Data Protection Act of 2020, establishing a Data Protection Agency in the Executive branch S. 3456, Consumer Data Privacy and Security Act of 2020, setting federal standards for data collection and processing Response to request from Rep. Adam Schiff on placement of advertising and key word blocking of topics related to COVID-19
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Advertising ADV
Comments to Federal Trade Commission on its guides for the use of endorsements and testimonials in advertising
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID P BUZBY | — |
| DANIEL L JAFFE | — |
| CHRISTOPHER OSWALD | — |
| MEGHAN SALOME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.